Bliss GVS Pharma dividend 2025
BLISSGVS
152.07
10.12 (-6.24%)Last updated on 10 Dec, 2025 | 13:12 IST
BUYSELL
The current prices are delayed, login to your account for live prices
LoginBliss GVS Pharma Dividend Details
Record Date
24-Jul-2025
Dividends Date
24-Jul-2025
Ex Date
24-Jul-2025
Dividend Type
Equity Share
Dividend Per Share
₹50.00
The Bliss GVS Pharma has declared a Equity Share dividend of 50 per share. Investors should note the record date of 24-Jul-2025, and the ex-dividend date 24-Jul-2025 to confirm eligibility for the payout. This move underscores the company’s ongoing efforts to enhance shareholder value through regular dividend distributions.
Bliss GVS Pharma Dividend History
| Record Date | Dividend Per Share | Dividend Type | Ex-Date |
|---|---|---|---|
| 24-Jul-2025 | ₹0.50 | Equity Share | 24-Jul-2025 |
Upcoming Dividends by Indian Companies
View More| Company | Dividends Ratio | Announcement | Record Date | Dividends Date |
|---|---|---|---|---|
| Steel City Securities Ltd. | 0.1 | 01-Dec-2025 | 11-Dec-2025 | 11-Dec-2025 |
Bliss GVS Pharma Dividend FAQs
The latest dividend declared by Bliss GVS Pharma is of 0.5 per share for the financial year as announced on 24-Jul-2025.
Registered shareholders who own Bliss GVS Pharma’s shares on or before the record date of 24-Jul-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 24-Jul-2025.
You can expect to receive Bliss GVS Pharma’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 24-Jul-2025. The record date is when Bliss GVS Pharma identifies eligible shareholders for the dividend payment.
The annual dividend paid by Bliss GVS Pharma varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Bliss GVS Pharma's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.